Log in

NASDAQ:OSMTOsmotica Pharmaceuticals News Headlines

$4.47
-0.13 (-2.83 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.43
Now: $4.47
$4.59
50-Day Range
$2.94
MA: $3.97
$4.62
52-Week Range
$2.20
Now: $4.47
$7.97
Volume112,300 shs
Average Volume283,398 shs
Market Capitalization$230.30 million
P/E RatioN/A
Dividend YieldN/A
Beta3.52

Headlines

Osmotica Pharmaceuticals (NASDAQ OSMT) News Headlines

Source:
DateHeadline
Zacks: Analysts Anticipate Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Will Announce Quarterly Sales of $40.34 MillionZacks: Analysts Anticipate Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Will Announce Quarterly Sales of $40.34 Million
www.americanbankingnews.com - May 17 at 3:48 AM
-$0.14 EPS Expected for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) This Quarter-$0.14 EPS Expected for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) This Quarter
www.americanbankingnews.com - May 15 at 6:41 PM
Heres What Analysts Are Forecasting For Osmotica Pharmaceuticals plc (NASDAQ:OSMT) After Its First-Quarter ResultsHere's What Analysts Are Forecasting For Osmotica Pharmaceuticals plc (NASDAQ:OSMT) After Its First-Quarter Results
finance.yahoo.com - May 15 at 1:50 PM
Here's What Analysts Are Forecasting For Osmotica Pharmaceuticals plc (NASDAQ:OSMT) After Its First-Quarter ResultsHere's What Analysts Are Forecasting For Osmotica Pharmaceuticals plc (NASDAQ:OSMT) After Its First-Quarter Results
finance.yahoo.com - May 15 at 1:50 PM
Q3 2020 EPS Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Lifted by AnalystQ3 2020 EPS Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Lifted by Analyst
www.americanbankingnews.com - May 15 at 12:30 PM
SVB Leerink Equities Analysts Increase Earnings Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT)SVB Leerink Equities Analysts Increase Earnings Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT)
www.americanbankingnews.com - May 15 at 9:07 AM
3 Biotech Stocks Under $4 That Could Surge Over 50%3 Biotech Stocks Under $4 That Could Surge Over 50%
finance.yahoo.com - May 15 at 8:49 AM
FY2023 EPS Estimates for Osmotica Pharmaceuticals PLC Boosted by SunTrust Banks (NASDAQ:OSMT)FY2023 EPS Estimates for Osmotica Pharmaceuticals PLC Boosted by SunTrust Banks (NASDAQ:OSMT)
www.americanbankingnews.com - May 14 at 6:05 PM
FY2023 EPS Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Decreased by SVB LeerinkFY2023 EPS Estimates for Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Decreased by SVB Leerink
www.americanbankingnews.com - May 14 at 6:05 PM
Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) Given Consensus Rating of "Buy" by AnalystsOsmotica Pharmaceuticals PLC (NASDAQ:OSMT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 14 at 4:58 AM
Osmotica Pharmaceuticals (NASDAQ:OSMT) Issues Quarterly  Earnings Results, Beats Expectations By $0.07 EPSOsmotica Pharmaceuticals (NASDAQ:OSMT) Issues Quarterly Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - May 13 at 8:23 PM
Osmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual ConferenceOsmotica Pharmaceuticals plc to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 13 at 6:18 PM
Osmotica Pharmaceuticals PLC (OSMT) CEO Brian Markison on Q1 2020 Results - Earnings Call TranscriptOsmotica Pharmaceuticals PLC (OSMT) CEO Brian Markison on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:15 PM
OSMOTICA PHARM (OSMT) Reports Q1 Loss, Tops Revenue EstimatesOSMOTICA PHARM (OSMT) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 12 at 10:15 PM
Osmotica Pharmaceuticals PLC (OSMT) Q1 2020 Earnings Call TranscriptOsmotica Pharmaceuticals PLC (OSMT) Q1 2020 Earnings Call Transcript
www.fool.com - May 12 at 9:31 PM
Osmotica Pharmaceuticals EPS beats by $0.14, beats on revenueOsmotica Pharmaceuticals EPS beats by $0.14, beats on revenue
seekingalpha.com - May 12 at 5:14 PM
Osmotica Pharmaceuticals (OSMT) Set to Announce Earnings on TuesdayOsmotica Pharmaceuticals (OSMT) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - May 11 at 10:57 AM
Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020
finance.yahoo.com - May 8 at 10:09 PM
OSMOTICA PHARM (OSMT) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseOSMOTICA PHARM (OSMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 7 at 2:44 PM
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q4 2019 Results - Earnings Call TranscriptOsmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 18 at 11:49 PM
Osmotica Pharmaceuticals PLC (OSMT) Q4 2019 Earnings Call TranscriptOsmotica Pharmaceuticals PLC (OSMT) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 18 at 11:49 PM
Osmotica Pharmaceuticals EPS of -$0.51Osmotica Pharmaceuticals EPS of -$0.51
seekingalpha.com - March 18 at 6:49 PM
Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2019 Business and Financial Update on March 18, 2020Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2019 Business and Financial Update on March 18, 2020
finance.yahoo.com - March 12 at 8:32 PM
Osmotica to Present at Barclays Global Healthcare Conference 2020Osmotica to Present at Barclays Global Healthcare Conference 2020
finance.yahoo.com - March 3 at 8:03 AM
Osmotica to Present at 9th Annual SVB Leerink Global Healthcare ConferenceOsmotica to Present at 9th Annual SVB Leerink Global Healthcare Conference
www.globenewswire.com - February 18 at 6:15 PM
Investors Who Bought Osmotica Pharmaceuticals (NASDAQ:OSMT) Shares A Year Ago Are Now Down 35%Investors Who Bought Osmotica Pharmaceuticals (NASDAQ:OSMT) Shares A Year Ago Are Now Down 35%
finance.yahoo.com - February 17 at 1:36 PM
26 Biotechnology Stocks Moving In Wednesdays After-Market Session26 Biotechnology Stocks Moving In Wednesday's After-Market Session
www.msn.com - January 23 at 1:49 AM
36 Healthcare Stocks Moving In Wednesdays After-Market Session36 Healthcare Stocks Moving In Wednesday's After-Market Session
www.benzinga.com - January 23 at 1:49 AM
Osmotica +14.5% amid insider purchasesOsmotica +14.5% amid insider purchases
seekingalpha.com - January 15 at 9:32 PM
Osmotica prices stock offering at $5; shares up 3% premarketOsmotica prices stock offering at $5; shares up 3% premarket
seekingalpha.com - January 9 at 5:04 PM
Osmotica Announces Pricing of Public Offering of Ordinary SharesOsmotica Announces Pricing of Public Offering of Ordinary Shares
finance.yahoo.com - January 8 at 9:27 PM
30 Stocks Moving In Mondays Mid-Day Session30 Stocks Moving In Monday's Mid-Day Session
www.msn.com - January 6 at 2:00 PM
Osmotica down 15% on equity offeringOsmotica down 15% on equity offering
seekingalpha.com - January 6 at 2:00 PM
Osmotica Announces Proposed Public Offering of Ordinary SharesOsmotica Announces Proposed Public Offering of Ordinary Shares
finance.yahoo.com - January 6 at 2:00 PM
OSMT or ILMN: Which Is the Better Value Stock Right Now?OSMT or ILMN: Which Is the Better Value Stock Right Now?
finance.yahoo.com - December 23 at 1:19 PM
Is OSMOTICA PHARM (OSMT) Stock Undervalued Right Now?Is OSMOTICA PHARM (OSMT) Stock Undervalued Right Now?
finance.yahoo.com - December 10 at 2:44 PM
Did Hedge Funds Drop The Ball On Osmotica Pharmaceuticals plc (OSMT) ?Did Hedge Funds Drop The Ball On Osmotica Pharmaceuticals plc (OSMT) ?
finance.yahoo.com - November 30 at 3:58 PM
Moving Average Crossover Alert: Osmotica PharmaceuticalsMoving Average Crossover Alert: Osmotica Pharmaceuticals
finance.yahoo.com - November 27 at 8:31 AM
FDA accepts Osmotica application for droopy eyelid drug; shares up 2%FDA accepts Osmotica application for droopy eyelid drug; shares up 2%
seekingalpha.com - November 20 at 1:47 PM
Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)
finance.yahoo.com - November 20 at 8:46 AM
Earnings Release: Heres Why Analysts Cut Their Osmotica Pharmaceuticals plc Price Target To US$8.50Earnings Release: Here's Why Analysts Cut Their Osmotica Pharmaceuticals plc Price Target To US$8.50
finance.yahoo.com - November 18 at 10:36 AM
Earnings Release: Here's Why Analysts Cut Their Osmotica Pharmaceuticals plc Price Target To US$8.50Earnings Release: Here's Why Analysts Cut Their Osmotica Pharmaceuticals plc Price Target To US$8.50
finance.yahoo.com - November 18 at 10:36 AM
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2019 Results - Earnings Call TranscriptOsmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 12:57 PM
Osmotica Pharmaceuticals EPS of -$2.15Osmotica Pharmaceuticals EPS of -$2.15
seekingalpha.com - November 14 at 8:39 PM
Osmotica Pharmaceuticals plc Reports Third Quarter 2019 ResultsOsmotica Pharmaceuticals plc Reports Third Quarter 2019 Results
finance.yahoo.com - November 14 at 8:39 PM
Osmotica Pharmaceuticals plc to Provide Third Quarter 2019 Business and Financial Update on November 15, 2019Osmotica Pharmaceuticals plc to Provide Third Quarter 2019 Business and Financial Update on November 15, 2019
finance.yahoo.com - November 8 at 1:52 PM
Kaskela Law LLC Announces Investigation of Osmotica Pharmaceuticals plc (OSMT) on Behalf of InvestorsKaskela Law LLC Announces Investigation of Osmotica Pharmaceuticals plc (OSMT) on Behalf of Investors
finance.yahoo.com - October 28 at 5:59 PM
OSMT Osmotica Pharmaceuticals plc Ordinary SharesOSMT Osmotica Pharmaceuticals plc Ordinary Shares
www.nasdaq.com - October 24 at 3:48 AM
Osmotica Pharmaceuticals plc Appoints Industry Executive Michael J. DeBiasi to Board of DirectorsOsmotica Pharmaceuticals plc Appoints Industry Executive Michael J. DeBiasi to Board of Directors
finance.yahoo.com - September 27 at 7:54 AM
Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)
finance.yahoo.com - September 18 at 12:22 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.